Relapsed/Refractory Peripheral T-cell Lymphoma
Showing 9976 - 10000 of >10,000
Infection Control Training Trial (Structured Training)
Not yet recruiting
- Infection Control Training
- Structured Training
- (no location specified)
Jan 23, 2023
Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer
Recruiting
- Lung Cancer Non-small Cell Stage IV
-
Athens, GreeceHellenic Cooperative Oncology Group
Nov 14, 2022
NSCLC Trial in Pittsburgh (M1774, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Pittsburgh, PennsylvaniaUPMC Cancer Center
May 22, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +5 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jul 14, 2022
Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
- Poziotinib Hydrochloride
- 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
- (no location specified)
Jul 18, 2022
Fatigue, Post-Acute COVID-19 Syndrome Trial in Hannover (Immunoadsorption vs. sham immunoadsorption)
Not yet recruiting
- Fatigue
- Post-Acute COVID-19 Syndrome
- Immunoadsorption vs. sham immunoadsorption
-
Hannover, Lower Saxony, GermanyHannover Medical School
Jul 24, 2023
Predicting Placental Pathologies by Ultrasound Imaging
Recruiting
- Intrauterine Growth Restriction
- +2 more
- Comprehensive Doppler Ultrasound of the Placenta
- Verasonics Ultrasound scanner (ultra-sensitive Doppler imaging)
-
Rochester, MinnesotaMayo Clinic
Mar 28, 2022
Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)
Active, not recruiting
- Melanoma Stage Iii
- +4 more
- Denosumab
- +2 more
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 20, 2022
to Lymphocyte Ratio in Cardiac Surgery
Completed
- Cardiac Surgery
-
Ankara, TurkeyAnkara City Hospital
Aug 5, 2022
Medication Adherence Trial (Adaptive Cell Phone Support, Computer-Delivered Cell Phone Support, Automated Text Reminders)
Not yet recruiting
- Medication Adherence
- Adaptive Cell Phone Support
- +2 more
- (no location specified)
Jan 30, 2023
Differentiated Thyroid Cancer (DTC) Trial in China (Lenvatinib, Placebo)
Completed
- Differentiated Thyroid Cancer (DTC)
- Lenvatinib
- Placebo
-
Beijing, Beijing, China
- +23 more
Jan 25, 2022
Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)
Completed
- Early Stage Breast Cancer
-
Boston, Massachusetts
- +3 more
Apr 11, 2022
Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)
Not yet recruiting
- Brain Metastases
- Renal Cell Carcinoma
- Nivolumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)
Recruiting
- Relapsing Multiple Sclerosis
-
Boston, MassachusettsPartners MS Center, 60 Fenwood Road
Jul 20, 2021
Sarcoma Trial in Shanghai (MASCT-I,PD1 Antibody,Apatinib)
Active, not recruiting
- Sarcoma
- MASCT-I,PD1 Antibody,Apatinib
-
Shanghai, Shanghai, ChinaShanghai Sixth People's Hospital
Nov 22, 2022
ALK-positive NSCLC Trial in Shanghai (Alkotinib Capsules)
Recruiting
- ALK-positive Non-small Cell Lung Cancer
- Alkotinib Capsules
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Nov 28, 2022
Patients With Systemic Lupus Erythematosus
Recruiting
- Lupus Nephritis
-
Bruxelles, BelgiumCliniques universitaires Saint-Luc
Jun 29, 2022
Primary Autoimmune Hemolytic Anemia Trial in Assiut,, Assiut (Cyclosporine, Rituximab)
Recruiting
- Primary Autoimmune Hemolytic Anemia
-
Assiut,, Assiut, Egypt
- +1 more
Oct 20, 2021
Affecting Progression of Bronchiectasis
Recruiting
- Bronchiectasis
- Pseudomonas aeruginosa colonization infection
- Macrolides
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Feb 7, 2023
Small Cell Lung Carcinoma Trial in Omaha (Durvalumab + Tremelimumab in combination with carboplatin and etoposide, Durvalumab in
Terminated
- Small Cell Lung Carcinoma
- Durvalumab + Tremelimumab in combination with carboplatin and etoposide
- Durvalumab in combination with carboplatin and etoposide
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 24, 2022
Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)
Not yet recruiting
- Advanced Renal Cell Carcinoma
- Botensilimab
- +3 more
- (no location specified)
Jun 23, 2023
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)
Active, not recruiting
- Graft-versus-host Disease
- Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
-
New York, New YorkNYU Langone Health
Aug 5, 2022
Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)
Recruiting
- Metastatic Renal Cell Carcinoma
- Brain Metastases
- Cabozantinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 10, 2023